| Individual Articles - Jul/Aug 2000 - Compounding for Hospice and Cancer Patients |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Hospice and the Role of the Compounding Pharmacist
Carling Maureen A
|
Jul/Aug 2000
Pg. 246-249
|
Nausea and Vomiting in Hospice Patients
Boomsma Diane
|
Jul/Aug 2000
Pg. 250-251
|
Ketamine for Pain in Hospice Patients
Wood Robert M
|
Jul/Aug 2000
Pg. 253-254
|
Custom-Making Medications for the Hospice Patient
Horwitz Robert
|
Jul/Aug 2000
Pg. 255-256
|
Body-Wash Formula
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Rinseless Shampoo
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Dry Mouth Spray
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Surviving Cancer - How the Compounding Pharmacist Can Help
Maddox Suzan
|
Jul/Aug 2000
Pg. 257-260
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
|
Jul/Aug 2000
Pg. 264-272
|
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 276-279
|
NADH Capsules
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 278
|
Short Communication: Compounding for Implantable Pumps
Molitor Richard
|
Jul/Aug 2000
Pg. 280
|
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
|
Jul/Aug 2000
Pg. 281-285
|
Profile of a Practice
Hudson Sonora
|
Jul/Aug 2000
Pg. 287
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2000
Pg. 288
|
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 289-293
|
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 296
|
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 297
|
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 298
|
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 299
|
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 300
|
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 301
|
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 302
|
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 303
|
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 304
|
Ondansetron HCl 8-mg/mL in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 305
|
Capsule and Tablet Diluents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 306-310
|
Basic Compounding Documentation: The Master Formula Form
Tenreiro Kim
|
Jul/Aug 2000
Pg. 313-312
|
Calculations
Prince Shelly J
|
Jul/Aug 2000
Pg. 314
|
Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Al-Achi Antoine, Greenwood Robert, Akin-Isijola Austin
|
Jul/Aug 2000
Pg. 315-317
|
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs
Jappinen Annaliisa L, Naaranlahti Toivo J, Kokki Hannu, Ojanen Tarja, Rasi Anu
|
Jul/Aug 2000
Pg. 318-319
|
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution
Fuhrman L Clifton, Godwin Donald A, Davis R Alan
|
Jul/Aug 2000
Pg. 320-323
|
